FDC Limited (NSE:FDC)
475.40
-3.95 (-0.82%)
Aug 1, 2025, 3:29 PM IST
CTI BioPharma Market Cap
FDC Limited has a market cap or net worth of 77.52 billion as of August 1, 2025. Its market cap has decreased by -3.70% in one year.
Market Cap
77.52B
Enterprise Value
72.36B
Revenue
21.08B
Ranking
n/a
PE Ratio
29.06
Stock Price
$475.40
Market Cap Chart
Since May 30, 2002, FDC Limited's market cap has increased from 2.73B to 77.52B, an increase of 2,742.20%. That is a compound annual growth rate of 15.53%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 77.52B | -4.55% |
Dec 31, 2024 | 81.22B | 25.96% |
Dec 29, 2023 | 64.48B | 43.15% |
Dec 30, 2022 | 45.04B | -12.27% |
Dec 31, 2021 | 51.34B | -8.36% |
Dec 31, 2020 | 56.03B | 54.43% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 3,910.20B |
Divi's Laboratories | 1,688.78B |
Cipla | 1,213.89B |
Apollo Hospitals Enterprise | 1,078.10B |
Mankind Pharma | 1,059.56B |
Zydus Lifesciences | 954.97B |
Fortis Healthcare | 648.70B |
Aurobindo Pharma | 627.15B |